Insights Into Taysha Gene Therapies Inc (TSHA) Exposure By Institutions

After Hours

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Most recently, Yahoo Finance reported about the stock as it publicized that Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4).

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.
Sponsored

Stocks Info

Taysha Gene Therapies Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Taysha Gene Therapies Inc is $282.31M. A total of 0.85 million shares were traded on the day, compared to an average of 2.19M shares.

Insider Activity

Insider trades are also considered as indicators of how a stock will perform in the future, in addition to stock predictions. During the recent three months, TSHA has seen 1 BUY and 0 SELL insider trades, representing the acquisition of 100,000 and the disposition of 0 shares. Over the last 12 months, there were 10 BUYs and 7 SELLs from insiders. Insiders purchased 18,212,526 shares during that period but sold 582,095.

In the most recent transaction, Manning Paul B bought 100,000 shares of TSHA for 1.63 per share on Nov 17. After the transaction, the 10% Owner now owns 16,566,667 company shares. In a previous transaction on Aug 24, Alam Kamran sold 33,000 shares at 2.33 per share. TSHA shares that Chief Financial Officer owns now total 258,042.

Among the insiders who bought shares, Manning Paul B acquired of 16,466,667 shares on Aug 16 at a per-share price of $0.90. This resulted in the 10% Owner holding 16,466,667 shares of TSHA after the transaction. In another insider transaction, Nolan Sean P. bought 444,444 shares at $0.90 per share on Aug 16. Company shares held by the Chief Executive Officer now total 1,535,545.

Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, TSHA has a high of $3.89 and a low of $0.50.

As of this writing, TSHA has an earnings estimate of -$0.11 per share for the current quarter. EPS was calculated based on a consensus of 10 estimates, with a high estimate of -$0.07 per share and a lower estimate of -$0.24. The company reported an EPS of -$0.38 in the last quarter, which was -22.60% lower than expectations of -$0.31.

Balance Sheet Annually/Quarterly

As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. TSHA’s latest balance sheet shows that the firm has $149.10M in Cash & Short Term Investments as of fiscal 2021. There were $63.09M in debt and $51.75M in liabilities at the time. Its Book Value Per Share was -$0.26, while its Total Shareholder’s Equity was $95.38M.

Analysts Opinion

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for TSHA is Buy with a score of 4.70.

Most Popular

Related Posts